Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFor most people, Mounjaro side effects ease within the first two to four weeks of starting or increasing a dose. Nausea, loose stools and fatigue are most common in the early days and tend to settle as the body adjusts — though the timeline varies from one person to the next. Mounjaro (tirzepatide) is a prescription-only medicine, so a GPhC-registered prescriber will discuss your personal side-effect profile as part of your clinical assessment, both at the start of treatment and at every follow-up review.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
You've just injected your first pen. By day three, maybe day four, nausea rolls in, a vague queasiness that sits at the back of your throat, sometimes worse after eating a larger meal than you expected to want. That is the scenario most people describe, and it usually peaks somewhere in the first week then begins to ease. The full side-effect picture for Mounjaro includes nausea, vomiting, diarrhoea, constipation, burping, indigestion, tiredness and headache, according to the NHS medicines page for tirzepatide. What most people are not told clearly enough is that these symptoms are not random: tirzepatide slows gastric emptying as part of how it reduces appetite. Your gut is responding to a genuine physiological change, not to something going wrong.
Practical steps that commonly help: eat smaller portions and stop before you feel full, avoid high-fat or highly processed meals in the first fortnight, stay well hydrated, and give the dose time. Symptoms that are severe enough to stop you eating or drinking anything for more than 24 hours are worth contacting your prescriber about, dehydration can compound other side effects quickly.
The adjustment cycle tends to repeat, to a lesser degree, each time the dose steps up. You settle into 2.5 mg, then 5 mg arrives and the first week feels familiar again. This is normal. For most patients each recurrence is milder than the one before it (the body has already learned something about the medicine) though that is not guaranteed for everyone. Loose stools and fatigue follow a similar pattern: prominent early, then fading. One misconception worth setting aside gently: many people assume side effects that persist past week two mean the treatment is wrong for them. In reality, some milder symptoms (occasional burping, slightly slower digestion) can linger at a low level throughout treatment without being medically concerning. The question is whether they are tolerable and stable, not whether they have vanished entirely.
If you are struggling with constipation specifically, fibre and fluid intake make a measurable difference. Your prescriber can advise on additional support if symptoms are persistent rather than transient.
Knowing when to act rather than wait is the part that matters most on an EDU-SAFETY page, so here it is plainly. Seek urgent medical attention if you develop severe abdominal pain that radiates toward your back, with or without vomiting. This symptom profile can indicate acute pancreatitis, which the MHRA highlighted in a Drug Safety Update in January 2026 as an infrequent but potentially serious risk with GLP-1 medicines. Do not wait to see whether it settles. Other symptoms that warrant prompt attention: signs of a serious allergic reaction (swelling of the face, lips or throat, difficulty breathing), severe or persistent vomiting leading to dehydration, sudden changes in vision, and significant changes in mood or thoughts of self-harm. The pancreatic cancer risk question is one our prescribers hear regularly, the evidence base for that concern is covered separately and is worth reading if it is on your mind. For a thorough look at the full list of the five most commonly reported Mounjaro side effects, including how each one typically resolves, there is dedicated detail available.
At nume, a real prescriber reads every consultation answer before anything is issued) and the same clinical review happens before every repeat order. Side-effect management is not a gap between appointments; it is part of the ongoing care. If something feels off between orders, our clinical team offers priority aftercare seven days a week. The free consultation is the starting point: it covers your medical history, current medications, and anything in your situation that changes how tirzepatide is likely to feel. For anyone weighing up whether treatment is right for them, our weight-loss treatment overview gives broader context. Our lead prescriber's profile sets out the clinical oversight behind the service. Side effects going away is not the whole picture, it is about knowing which ones will, which ones to manage, and which ones mean stop and call.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.